Elevance Beats The Street
Elevance Health beat Wall Street expectations for Q1 2026 and raised its full-year guidance. It has instituted a performance improvement and turnaround program and is managing medical costs. The company reported $1.8 billion in Q1, down 19.2% from $2.2 billion in the prior-year quarter.
Revenue in the quarter was $50.2 billion, up 2.6% from Q1 2025. Elevance had a $1.76 billion profit in Q1, down 19.4% year over year.
It continues to have struggles in Medicare Advantage (MA) and Medicaid. On MA, it faces a potential exposure over risk adjustment of up to $1.5 billion. On Exchanges, it reports that more and more are choosing cheaper Bronze plans due to premium hikes and enhanced subsidy expiration.
Elevance also says it will invest $1 billion in digital and AI capabilities.
Additional articles: https://www.modernhealthcare.com/insurance/mh-elevance-health-earnings-stock-price/ and https://www.beckerspayer.com/virtual-care/inside-elevances-1b-ai-investment/ and https://www.beckerspayer.com/financial/elevance-reports-1-76b-profit-in-q1/ and https://www.fiercehealthcare.com/payers/elevance-health-raises-2026-outlook-it-posts-18b-q1-profit
(Some articles may require a subscription.)
#elevancehealth #healthplans #margins #medicareadvantage #exchanges #aca #medicaid
— Marc S. Ryan
